Axogen (AXGN) Return on Invested Capital (2012 - 2013)
Axogen (AXGN) recorded quarterly Return on Invested Capital of 0.05% in Q4 2013, down 229.61% quarter-over-quarter from 0.03% in Q3 2013, and down 4.0% on a YoY basis from 0.05% in Q4 2012.
Axogen (AXGN) Return on Invested Capital (2012 - 2013) Analysis & Trends
Axogen's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.05% for Q4 2013.
- In Q4 2013, Return on Invested Capital fell 4.0% year-over-year to 0.05%; the TTM figure through Dec 2013 stood at 0.05% (down 4.0% YoY), while the FY2012 annual figure was 0.0%, changed N/A from the prior year.
- Return on Invested Capital was 0.05% for Q4 2013 at Axogen, down from 0.03% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q3 2013 to a low of 0.05% in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.00% |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -0.05% |
| Sep 30, 2013 | 0.03% |
| Jun 30, 2013 | 0.01% |
| Dec 31, 2012 | -0.01% |
| Sep 30, 2012 | -0.01% |